Cytotoxic activity of extracts of marine sponges from NW Spain on a neuroblastoma cell line

Environmental Toxicology and Pharmacology

Volumn 32, Issue 3, 2011, Pages 430-437

  Ferreira, Martiña ^a   Cabado, Ana G ^a   Chapela, María José ^a   Fajardo, Paula ^a   Atanassova, Miroslava ^a   Garrido, Alejandro ^a   Vieites, Juan M ^a   Lago, Jorge ^a  

^a ANFACO CECOPESCA   (Spain)

Author keywords

Apoptosis; Bioactive compound; Cytotoxicity; Marine sponge; Neuroblastoma

Indexed keywords

BIOLOGICAL MARKER; NATURAL PRODUCT; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HALICHONDRIA PANICEA; HALICLONA; HUMAN; HUMAN CELL; INCUBATION TIME; INTRACELLULAR TRANSPORT; MARINE SPECIES; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA; NEUROBLASTOMA CELL; OPHLITASPONGIA SERIATA; PACHYMATISMA JOHNSTONIA; PRIORITY JOURNAL; SEASHORE; SPAIN; SPECIES COMPARISON;

ANIMALS; ANTINEOPLASTIC AGENTS; AQUATIC ORGANISMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROBLASTOMA; PORIFERA; PROPIDIUM; SPAIN; TISSUE EXTRACTS;

HALICHONDRIA PANICEA; HALICLONA SP.; JOHNSTONIA; OPHLITASPONGIA SERIATA; PACHYMATISMA; SUBERITES MASSA;

EID: 80054112137     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.08.012     Document Type: Article

References (52)

1. Andavan G.S.B., Lemmens-Gruber R. Cyclodepsipeptides from marine sponges: natural agents for drug research. Mar. Drugs 2010, 8:810-834.
2. Bergmann W., Feeney R.J. The isolation of a new thymine pentoside from sponges. J. Am. Chem. Soc. 1950, 72:2809-2810.
3. Bergmann W., Feeney R.J. Nucleosides of sponges. J. Org. Chem. 1951, 16:981-987.
4. Blunt J.W., Copp B.R., Hu W.P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2007, 24:31-86.
5. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. 1995, 92:7162-7166.
6. Cabado A.G., Leira F., Vyeites M.R., Vieites J.M., Botana L.M. Cytoskeletal disruption is the key factor that triggers apoptosis in okadaic acid-treated neuroblastoma cells. Arch. Toxicol. 2004, 78:74-85.
7. Casapullo A., Minale L., Zollo F. Paniceins and related sesquiterpenoids from the Mediterranean sponge Reniera fulva. J. Nat. Prod. 1993, 56:527-533.
8. Casapullo A., Pinto O.C., Marzocco S., Autore G., Riccio R. 3-Alkylpyridinium alkaloids from the Pacific sponge Haliclona sp. J. Nat. Prod. 2009, 72:301-303.
9. Charan R.D., Garson M.J., Brereton I.M., Willis A.C., Hooper J.N.A. Haliclonacyclamines A and B, cytotoxic alkaloids from the tropical marine sponge Haliclona sp. Tetrahedron 1996, 52:9111-9120.
10. Cimino G., De Stefano S., Minale L. Paniceins, unusual aromatic sesquiterpenoids linked to a quinol or quinone system from the marine sponge Halichondria panicea. Tetrahedron 1973, 29:2565-2570.
11. Da Frota M.L.C., Braganhol E., Canedo A.D., Klamt F., Apel M.A., Mothes B., Lerner C., Battastini A.M.O., Henriques A.T., Moreira J.C.F. Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture. Invest. New. Drugs 2009, 27:13-20.
12. Da Frota M.L.C., Braganhol E., Canedo A.D., Klamt F., Apel M.A., Mothes B., Lerner C., Battastini A.M.O., Henriques A.T., Moreira J.C.F. Extracts of marine sponge Polymastia janeirensis induce oxidative cell death through a caspase-9 apoptotic pathway in human U138MG glioma cell line. Invest. New. Drugs 2009, 27:440-446.
13. Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000, 10:369-377.
14. Ebada S.S., Lin W.H., Proksch P. Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance. Mar. Drugs 2010, 8:313-346.
15. Edinger A.L., Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 2004, 16:663-669.
16. Erickson K.L., Beutler J.A., Cardellina J.H., Boyd M.R. Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. J. Org. Chem. 1997, 62:8188-8192.
17. Faulkner D.J. Marine natural products. Nat. Prod. Rep. 1998, 158:113-158.
18. Field J.J., Singh A.J., Kanakkanthara A., Halafihi T., Northcote P.T., Miller J.H. Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. J. Med. Chem. 2009, 52:7328-7332.
19. Garrido L., Zubia E., Ortega M.J., Salva J. New furanoterpenoids from the sponge Spongia officinalis. J. Nat. Prod. 1997, 60:794-797.
20. Hayot C., Debeir O., Van Ham P., Van Damme M., Kiss R., Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol. Appl. Pharmacol. 2006, 211:30-40.
21. Jordan M.A., Kamath K., Manna T., Okouneva T., Miller H.P., Davis C., Littlefield B.A., Wilson L. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Mol. Cancer Ther. 2005, 4:1086-1095.
22. Kashman Y., Koren-Goldshlager G., Gravalos G., Schleyer M. Halitulin, a new cytotoxic alkaloid from the marine sponge Haliclona tulearensis. Tetrahedron Lett. 1999, 40:997-1000.
23. Lago J., Santaclara F., Vieites J.M., Cabado A.G. Collapse of mitochondrial membrane potential and caspases activation are early events in okadaic acid-treated Caco-2 cells. Toxicon 2005, 46:579-586.
24. Lang S., Beil W., Tokuda H., Wicke C., Lurtz V. Improved production of bioactive glucosylmannosyl-glycerolipid by sponge-associated Microbacterium species. Mar. Biotechnol. 2004, 6:152-156.
25. Laport M.S., Santos O.C.S., Muricy G. Marine sponges: potential sources of antimicrobial drugs. Curr. Pharm. Biotechnol. 2009, 10:86-105.
26. Lebar M.D., Heimbenger J.L., Baker B.J. Cold-water marine natural products. Nat. Prod. Rep. 2007, 24:774-797.
27. Leira F., Vieites J.M., Vieytes M.R., Botana L.M. Apoptotic events induced by the phosphatase inhibitior okadaic acid in normal human lung fibroblasts. Toxicol. In Vitro 2001, 15:199-208.
28. Lippert H., Brinkmeyer R., Mulhaupt T., Iken K. Antimicrobial activity in sub-Arctic marine invertebrates. Polar Biol. 2003, 26:591-600.
29. Mayer A.M.S., Gustafson K.R. Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds. Eur. J. Cancer 2008, 44:2357-2387.
30. Mayer A.M.S., Rodríguez A.D., Berlinck R.G.S., Hamman M.T. Marine pharmacology in 2005-6: marine compounds with antihelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. BBA Gen. Subjects 2009, 1790:283-308.
31. Miller J.H., Rouwé B., Gaitanos T.N., Hood K.A., Crume K.P., Bäckström B.T.B., La Flamme A.C. Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. Apoptosis 2004, 9:785-796.
32. Miller J.H., Singh A.J., Northcote P.T. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide. Mar. Drugs 2010, 8:1059-1079.
33. Motohashi K., Takagi M., Shin-ya K. Tetracenoquinocin and 5-iminoaranciamycin from a sponge-derived Streptomyces sp. Sp080513GE-26. J. Nat. Prod. 2010, 73:755-758.
34. Ortega M.J., Zubia E., Carballo J.L., Salva J. Fulvinol, a new long-chain diacetylenic metabolite from the sponge Reniera fulva. J. Nat. Prod. 1996, 59:1069-1071.
35. Pajic I., Kljajic Z., Dogovic N., Sladic D., Juranic Z., Gasic M.J. A novel lectin from the sponge Haliclona cratera: isolation, characterization and biological activity. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2002, 132:213-221.
36. Queiroz A.F.S., Silva R.A., Moura R.M., Dreyfuss J.L., Paredes-Gamero E.J., Souza A.C.S., Tersariol I.L.S., Santos E.A., Nader H.B., Justo G.Z., de Sales M.P. Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells. Cancer Chemother. Pharmacol. 2009, 63:1023-1033.
37. Rueda A., Zubia E., Ortega M.J., Carballo J.L., Salva J. New cytotoxic metabolites from the sponge Cacospongia scalaris. J. Org. Chem. 1997, 62:1481-1485.
38. Rueda A., Zubia E., Ortega M.J., Carballo J.L., Salva J. New metabolites from the sponge Spongia agaricina. J. Nat. Prod. 1998, 61:258-261.
39. Sangrajrang S., Zidane M., Berda P., More M.T., Calvo F., Fellous A. Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines. Cancer Chemother. Pharm. 2000, 45:120-126.
40. Schneemann I., Kajahn I., Ohlendorf B., Zinecker H., Erhard A., Nagel K., Wiese J., Imhoff J.F. Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. J. Nat. Prod. 2010, 73:1309-1312.
41. Shin J.H., Seo Y.W., Cho K.W., Rho J.R., Paul V.J. Osirisynes A-F, highly oxygenated polyacetylenes from the sponge Haliclona osiris. Tetrahedron 1998, 54:8711-8720.
42. Sipkema D., Franssen M.C.R., Osinga R., Tramper J., Wijffels R.H. Marine sponges as pharmacy. Mar. Biotechnol. 2005, 7:142-162.
43. Tachibana K., Scheuer P.J., Tsukitani Y., Kikuchi H., Van Engen D., Clardy J., Gopichand Y., Schmitz F.J. Okadaic acid, a cytotoxic polyether from two marine species of the genus Halichondria. J. Am. Chem. Soc. 1981, 103:2469-2471.
44. Tadesse M., Gulliksen B., Strøm M.B., Styrvold O.B., Haug T. Screening for antibacterial and antifungal activities in marine benthic invertebrates from northern Norway. J. Invertebr. Pathol. 2008, 99:286-293.
45. Twelves C., Cortes J., Vahdat L.T., Wanders J., Akerele C., Kaufman P.A. Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer. Clin. Breast Cancer. 2010, 10:160-163.
46. Uriz M.J., Becerro M.A., Tur J.M., Turon X. Location of toxicity within the Mediterranean sponge Crambe crambe (Demospongiae: Poecilosclerida). Mar. Biol. 1996, 124:583-590.
47. Valverde I., Lago J., Vieites J.M., Cabado A.G. Neuroblastoma cells a cell model to study BADGE (Bisphenol A diglycidyl-ether) and BFDGE (Bisphenol F diglycidyl-ether) cytotoxicity. Focus on Neuroblastoma Research 2007, 119-147. Nova Science Publishers Inc., New York. J.A. Fernandes (Ed.).
48. Valverde I., Lago J., Vieites J.M., Cabado A.G. Characteristics of palytoxin-induced cytotoxicity in neuroblastoma cells. Toxicol. In Vitro 2008, 22:1432-1439.
49. Warabi K., Zimmerman W.T., Shen J.K., Gauthier A., Robertson M., Finlay B.B., van Soest R., Andersen R.J. Pachymoside A - a novel glycolipid isolated from the marine sponge Pachymatisma johnstonia. Can. J. Chem.-Can. Rev. Chim. 2004, 82:102-112.
50. Wicke C., Huners M., Wray V., Nimtz M., Bilitewski U., Lang S. Production and structure elucidation of glycoglycerolipids from a marine sponge-associated Microbacterium species. J. Nat. Prod. 2000, 63:621-626.
51. Zidane M., Pondaven P., Roussakis C., More M.T. Effects in vitro of pachymatismin, a glycoprotein from the marine sponge Pachymatisma johnstonii, on a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6). Anticancer Res. 1996, 16:2805-2812.
52. Zidane M., Pondaven P., Roussakis C., Quemener B., More M.T. Pachymatismin: a novel cytotoxic factor from the marine sponge (Pachymatisma johnstonii). Comp. Biochem. Physiol. C: Toxicol. Endocrinol. 1996, 115:47-53.